BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

RemeGen and Innovent Collaborate on Clinical Trials for Advanced Solid Tumors

RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, announce...

July 10, 2023 | News

280 Bio receives IND approval from the FDA for YL-17231

80Bio, Inc. a clinical stage biotechnology company focused on the development of precision oncology medicines, today announced that the U.S. Food and Drug ...

July 10, 2023 | News

GeneQuantum Healthcare and Aimed Bio collaborate to develop 5 innovative ADC drugs

Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...

July 07, 2023 | News

PrecisionLife licenses Oxford data for personalized endometriosis treatments

PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the Univ...

July 07, 2023 | News

GenScript Doubles cGMP sgRNA and Non-Viral DNA Payload Manufacturing Capacity

GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its cGMP manufacturing capacity...

July 07, 2023 | News

China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy

RareStone Group, a rare disease-focused company aiming to establish the first rare disease ecosystem in China, announced that on June 30, the Chi...

July 05, 2023 | News

FDA Approves Cu-64 SAR-bisPSMA Phase III Trial for Prostate Cancer

FDA agreement for a pivotal Phase III trial for 64Cu SAR-bisPSMA diagnostic in prostate cancer Phase III trial design based on&n...

July 05, 2023 | News

Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China

The pivotal clinical trial approved in China will evaluate the efficacy and safety of Glecirasib as a single agent for the second line treatment ...

July 05, 2023 | News

Sanyou Partners with Hangzhou Zhongmei Huadong Pharmaceutical to Drive Drug R&D

This license is a continuation of the strategic partnership agreement signed by both parties in Nov. 2020. As a cutting-edge high-tech biotechnology e...

June 29, 2023 | News

INOVIQ's SubB2M/CA15-3 Breast Cancer Test Shows Excellent Clinical Data

INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...

June 28, 2023 | News

Hong Kong Polytechnic University researchers develop Optoelectronic Graded Neurons

he tiny visual systems of flying insects have inspired researchers of the Hong Kong Polytechnic University (PolyU) to develop Optoelectronic Graded Neurons...

June 28, 2023 | News

Lion TCR Raises $40M in Series B2 Funding, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy

The funds raised will be used primarily to support Lion TCR's clinical trials on hepatitis B virus (HBV)-specific TCR T cell therapy, while also facilitati...

June 28, 2023 | News

SK bioscience and the Peter Doherty Institute for Infection and Immunity Join Forces Against Influenza

SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the Peter Doherty Institute for Infection and Immunity...

June 27, 2023 | News

CStone Receives China NMPA Approval for GAVRETO® in First-Line Treatment of RET Fusion-Positive Lung Cancer.

The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...

June 27, 2023 | News

Stay Connected